InvestorsHub Logo

JediMozart

10/30/21 5:03 PM

#11199 RE: Dapper10 #11198

Polarization technology patent is where the money is … also worth noting, escozine was initially being put through the FDA as an orphan drug for cancer uses it only got switched over to a Covid drug in order to get it through the FDA process quicker .. the company has much to offer .. Covid is not the catalyst that will drive this company to great successes instead it’s the science the patent scorpion venom research imunapen and more skus to follow … escozine cancer research
AELIA escozine MedolifeRx QNTA

Ps covid sadly isn’t going anywhere.. the beautiful thing about the scorpion ranch expansion is it will allow the escozine to be mass produced and subsequently price per unit will come down - escozine is now been adopted by the DR to use with their covid protocol… other Latin countries surely will follow …. Many countries are utilizing OTHER solutions to combat civid besides relying on vaccines … speaking of vaccine it’s worth also noting escozine has been shown when used along with receipt of vaccine to reduce side affects

$cience QNTA $$$$ I’m in this one for the long haul. GLTA